Targeting the Endocannabinoid System for Prevention or Treatment of Chemotherapy-Induced Neuropathic Pain: Studies in Animal Models
There is a scarcity of drugs to either prevent or properly manage chemotherapy-induced neuropathic pain (CINP). Cannabis or cannabinoids have been reported to improve pain measures in patients with neuropathic pain. For this review, a search was done in PubMed for papers that examined the expression...
Saved in:
Main Author: | Willias Masocha |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Pain Research and Management |
Online Access: | http://dx.doi.org/10.1155/2018/5234943 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Anticonvulsant Enaminone E139 Attenuates Paclitaxel-Induced Neuropathic Pain in Rodents
by: Dhandapani Thangamani, et al.
Published: (2013-01-01) -
Neuropathic Pain in Animal Models of Nervous System Autoimmune Diseases
by: David H. Tian, et al.
Published: (2013-01-01) -
Methadone in the Treatment of Neuropathic Pain
by: Bruno Gagnon, et al.
Published: (2003-01-01) -
Endocannabinoids and Reproduction
by: Rosaria Meccariello, et al.
Published: (2014-01-01) -
Cannabinoids and the endocannabinoid system in liver diseases
by: Anna Parfieniuk-Kowerda, et al.
Published: (2024-12-01)